Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 28Withdrawn 4Recruiting 4Unknown 1Terminated 1

Sponsor Class

OTHER 38INDUSTRY 7OTHER_GOV 6NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 13Leukemia, Myeloid, Acute 12Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms 6Head and Neck Neoplasms 6Fallopian Tube Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Vulvar Neoplasms 3Recurrence 3Lymphoma, Non-Hodgkin 3Lymphoma 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Fatigue 3Depression 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Stress Disorders, Post-Traumatic 2Small Cell Lung Carcinoma 2

Interventions

irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × NETWORK × Osteosarcoma × Clear all
NCT02013336 2022-03-31

Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

South Plains Oncology Consortium

Phase 1 Unknown
30 enrolled
CNSSarcoma

Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡